BAM15

Compound Overview

BAM15 is a Nexus-only small-molecule research compound generally discussed in mitochondrial bioenergetics workflows. The supplied chemistry record identifies it as a mitochondrial protonophore / uncoupler, a classification used in research contexts where investigators examine oxidative phosphorylation and mitochondrial energy handling under controlled laboratory conditions.

BAM15 is not a peptide, and the current product record does not include an amino-acid sequence, peptide sequence display, or component list. For this reason, the technical framing on this page follows the supplied small-molecule identifiers: CAS number, molecular formula, molecular weight, classification, physical-form note, and research-use restriction.

The Nexus product record currently lists the available format as an oral tablet. Because no final strength, tablet composition, excipient profile, or SKU is included in the provided source, formulation-specific details should be confirmed against the final product label and supplier documentation before laboratory use.

Research Background & Published Literature

The supplied research background is narrow. It states that BAM15 is generally discussed in mitochondrial bioenergetics workflows and used in oxidative-phosphorylation research as a small-molecule mitochondrial protonophore / uncoupler. No peer-reviewed paper titles, authors, study models, experimental concentrations, assay protocols, or outcome claims were provided in the source data.

Two external source references are included in the BAM15 research record for identity and specification context:

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Kenwood et al. (2014) — Mol Metab
• Alexopoulos et al. (2020) — Nat Commun
• Axelrod et al. (2020) — EMBO Mol Med

Storage, Handling & Stability Guidelines

The supplied storage guidance states: store powder at -20°C or per supplier COA, and protect from light and moisture. Because the active Nexus catalog entry currently lists an oral tablet format while the chemistry record also references powder, laboratories should defer to current supplier documentation, product labeling, and any available lot-specific COA before setting final storage procedures.

• Protect BAM15 material from unnecessary light exposure during storage and handling.
• Minimize moisture exposure by keeping containers closed when material is not actively being handled.
• For powder material, use -20°C storage unless current supplier documentation or COA guidance specifies otherwise.
• For tablet-format inventory, confirm storage conditions against the final product label or lot-specific documentation before use.
• Use appropriate PPE and institutional chemical-safety procedures for small-molecule research reagents.
• Maintain clear internal traceability records for product name, received format, storage condition, handling date, and operator initials.

No reconstitution solvent, post-opening stability interval, tablet excipient list, or shelf-life study was provided in the source data. Those values should not be assumed from this page.

Lab Verification

Nexus maintains research-compound verification records through the Lab Verified archive. In general terms, lab verification may include HPLC review for chromatographic profile and purity assessment, along with Mass Spectrometry (MS) review for molecular identity confirmation where lot-level documentation is available.